Roivant Sciences Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2025 | — | $4.69B | $2.72B |
| FY2026 | — | $4.53B | $1.42B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2025 | — | $4.69B | $2.72B |
| FY2026 | — | $4.53B | $1.42B |